Is Aripiprazole recalled?
29 FDA recalls mention Aripiprazole. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Aripiprazole.
Class II · Moderate risk Ongoing May 27, 2026
Reason Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Class II · Moderate risk Ongoing Aug 28, 2025
Reason Superpotent drug
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class II · Moderate risk Terminated Mar 20, 2023
Reason cGMP Deviations
Class II · Moderate risk Ongoing Mar 17, 2023
Reason Out of specification (OOS) for Spectroscopic Identification test by IR.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Feb 7, 2023
Reason CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk Terminated Jul 7, 2022
Reason Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.
Class II · Moderate risk Terminated Jan 26, 2022
Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk Terminated Nov 18, 2020
Reason Failed Dissolution Specifications: Out of specification for dissolution.
Class II · Moderate risk Terminated Nov 17, 2020
Reason FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole…
Class II · Moderate risk Terminated Nov 11, 2020
Reason Failed Dissolution Specifications: Out of specification for dissolution.
Class II · Moderate risk Terminated Jun 10, 2020
Reason Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.
Class III · Low risk Terminated Sep 17, 2018
Reason Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions…
Class III · Low risk Terminated Sep 17, 2018
Reason Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions…
Class II · Moderate risk Terminated Jan 19, 2018
Reason CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Class II · Moderate risk Terminated Jan 10, 2018
Reason CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Class III · Low risk Terminated Dec 27, 2016
Reason Superpotent Drug; out of specification results for assay (manufacturer)